Investing.com - Genmab AS reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Genmab AS announced earnings per share of $0.81 on revenue of $864.17M. Analysts polled by Investing.com anticipated EPS of $0.86 on revenue of $837.86M.
Genmab AS shares are up 69.59% from the beginning of the year and are trading at $37.87 , is-new-52-week-high.They are outperforming the Nasdaq which is up 23.52% from the start of the year.
Genmab AS follows other major sector earnings this month
Genmab AS's report follows an earnings beat by Tencent ADR on Wednesday, who reported EPS of $0.49 on revenue of $16.54B, compared to forecasts EPS of $0.41 on revenue of $16.04B.
L’Oreal ADR had beat expectations on July 30 with second quarter EPS of $3.82 on revenue of $6.92B, compared to forecast for EPS of $0.85 on revenue of $6.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar